Baseline (1987-89) measures
|
n=2612
|
n=4900
|
n=2365
|
Male, % |
45.7 |
44.7 |
44.5 |
Age 45-54 y, % |
53.1 |
52.1 |
52.7 |
55-64 y, % |
46.9 |
47.9 |
47.3 |
Diabetes, % |
7.9 |
8.1 |
8.2 |
Obese (BMI ≥30), % |
23.2 |
20.9 |
20.7 |
Current cigarette smoker, % |
25.5 |
25.0 |
24.6 |
Hypertension, % |
26.6 |
25.5 |
25.2 |
Hypercholesterolemia, % |
64.2 |
63.4 |
63.0 |
Framingham 10-year CHD risk ≥5%, % |
28.2 |
27.4 |
26.1 |
Carotid Intima Media Thickness (mm), median |
0.70 |
0.70 |
0.69 |
Carotid plaque, % |
33.6 |
33.7 |
34.3 |
Visit 2 (1990-92) measures
|
n=2401
|
n=4467
|
n=2156
|
HbA1c (%), median |
5.4 |
5.4 |
5.4 |
Visit 4 (1996-98) measures
|
n=1878
|
n=3444
|
n=1663
|
C-reactive protein (mg/L), median |
2.2 |
2.1 |
2.2 |
Troponin T (μg/L), median |
0.004 |
0.004 |
0.004 |
NT-proBNP (pg/mL), median |
71.3 |
70.7 |
68.8 |
LpPLA2 (μg/L), median |
233 |
233 |
230 |
Cystatin C (mg/L), median |
0.80 |
0.79 |
0.79 |